Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Real-World Treatment Patterns, Time to Next Treatment, and Economic Outcomes in Relapsed or Refractory Multiple Myeloma Patients Treated with Pomalidomide or Carfilzomib

PaperCitations, authors & open-access status

Real-World Treatment Patterns, Time to Next Treatment, and Economic Outcomes in Relapsed or Refractory Multiple Myeloma Patients Treated with Pomalidomide or Carfilzomib is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 38 citations, 2017 year and bronze oa status.

38
Citations
2017
Year
bronze
OA Status

Related on ScholarIQ

Rolin L. Wade
Author
Journal of Managed Care & Specialty Pharmacy
Journal
Multiple Myeloma Research and Treatments
Topic
Multiple Myeloma Research and Treatments
Topic
Economic and Financial Impacts of Cancer
Topic
Cancer Treatment and Pharmacology
Topic
470M+ articles · free account